TMCnet - World's Largest Communications and Technology Community



Equillium to Present at Leerink Partners Global Healthcare Conference
[February 21, 2019]

Equillium to Present at Leerink Partners Global Healthcare Conference

LA JOLLA, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immune-inflammatory disorders, announced today that Bruce Steel, Equillium’s president and chief business officer, will present at the Leerink Partners 8th Annual Global Healthcare Conference on Thursday, February 28, 2019. 

Date:   Thursday, February 28, 2019
Time:   10:00 AM Eastern Time | 7:00 AM Pacific Time
Location:   Lotte New York Palace in New York, NY

A live webcast of the presentation will be available under the “Investors” section of the Company’s website at Replays will be available for 30 days following each webcast.

About Equillium
Equillium is a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders with high unmet medical need.

Equillium’s initial product candidate, EQ001 (itolizumab), is a clinical-stage, first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in the activity and trafficking of Teff cells that drive a number of immuno-inflammatory diseases. Itolizumab is a clinically-validated therapeutic that has demonstrated a favorable safety and tolerability profile. Equillium acquired rights to EQ001 through an exclusive partnership with Biocon Limited. Equillium believes that EQ001 has the potential to be a best-in-class disease modifying therapeutic and is advancing EQ001 into clinical development in multiple immuno-inflammatory indications with high unmet medical need. For more information, visit

Investor Contact

Media Contact
Heidi Chokeir, Ph.D.
Canale Communications

Equillium_FullColor_RGB-300 - transparent.png

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2019 Technology Marketing Corporation. All rights reserved | Privacy Policy